Madam Chair, I thank the member for his kind words. These are long nights for all of us, and I appreciate that we are together, even if we are so virtually.
As I said, I am confident in the vaccine portfolio we have acquired for Canadians, including doses of Pfizer, Moderna and AstraZeneca, which are three vaccines being reviewed right now by Health Canada. They are under regulatory review.
We work with Americans and the European Union, sharing data so we can quickly assess these vaccines together and ensure, to the best of our ability, that we have no data gaps. As soon as those vaccines are proven to be safe here in Canada by our regulators, we will be able to deploy them in Canada.